Objective: To examine the potential impact of different models of folate fortification of Australian foods on the folate intakes of older Australians. Design: Dietary data were collected using a food frequency questionnaire from people attending a populationbased health study. Setting: Two postcode areas west of Sydney, Australia. Subjects: A total of 2895 people aged over 49 y, obtained from a door knock census (79% of 3654 subjects examined). Main outcome measures: The folate intake in this population was estimated using four different models: (1) prefortification folate values; (2) current voluntary folate fortification in Australia; (3) universal fortification of all foods permitted to add folate, at 25% recommended dietary intake (RDI) per reference serve; and (4) universal fortification of all foods permitted to add folate, at 50% RDI per reference serve. The increased bioavailability of synthetic folic acid (SFA) was included in the analysis. Results: At current voluntary folate fortification, approximately 65% of this population consume 320 mg dietary folate equivalents (DFE) or more per day from diet and supplements, and 0.4% (n ¼ 10) consume greater than the recommended upper safety level of 1000 mg from SFA. More than 95% of this older population would be expected to consume more than 320 mg DFE from diet and supplements with universal fortification at 50% of the RDI, and 0.5% (n ¼ 14) may consume greater than 1000 mg=day of SFA. Conclusions: There is unlikely to be a large increase in the proportion of older persons who are likely to consume more than the upper safety level of intake with universal folate fortification. As most of those who currently or are predicted to consume over 1000 mg SFA take supplements containing folic acid, it is highly recommended that vitamin B 12 be included in any vitamin supplements containing folate.
Introduction
Several studies have shown that higher periconceptual folate intake can prevent neural tube defects (NTD) in newborn babies (Lumley et al, 2000; Berry et al, 1999) . As a preventive measure, folate fortification of commonly consumed foods has been introduced in Australia, USA, UK and several European countries to increase folate intake among women of childbearing age.
Health authorities have the responsibility to ensure that any public health intervention does more good than harm and that potential benefits and side effects are monitored. Folate fortification of food has the potential to confer important health benefits to older persons, but may carry some health risk. A fundamental concern about the safety of folate fortification is the potential masking of vitamin B 12 deficiency (Joosten et al, 1993; Baik and Russell, 1999; Mills, 2000) . A higher folate intake will correct the megaloblastic anaemia of both folate and vitamin B 12 deficiency, but neurologic sequelae associated with B 12 deficiency may not be apparent and could progress undetected (Allen et al, 1990) , whereas a low folate intake is associated with elevated total blood homocysteine (Selhub et al, 1993 Jacques et al, 1999) , and an improved folate status may reduce cardiovascular disease (CVD) risk by reducing homocysteine (Eikelboom et al, 1999; Stampfer et al, 1992; Nygard et al, 1995; Welch & Loscalzo, 1998; Tucker et al, 1996) . One study has estimated that around 10% of CVD may be attributable to moderately elevated total homocysteine levels (Boushey et al, 1995) . A recent meta-analysis has shown that folate supplementation lowers plasma homocysteine (Homocysteine Lowering Trialists' Collaboration, 1998), although randomized trials have not yet demonstrated that lowering homocysteine would reduce CVD risk.
While potential benefits are likely to outweigh the risks for young women, the risks for older persons may outweigh the potential benefits, depending on the folate fortification program (NHMRC, 1994; US DHHS, 1996; Romano et al, 1995) . Before the impact of folate fortification on older persons can be predicted, more information is needed regarding (a) the usual folate intake in older persons, (b) the prevalence and clinical significance of B 12 deficiency and (c) the potential benefit for increased folate to reduce CVD risk.
The purpose of our report is to investigate the impact of voluntary folate fortification of common Australian food items on dietary folate intake and dietary folate equivalents in a population-based sample of older Australians. We also used two models of universal fortification to determine potential folate intake, and to quantify possible associated benefits and risks. Additionally, folate is calculated using Dietary Folate Equivalents, which allow for the increased absorption of synthetic folic acid, as described and used in IOM (1998) and Lewis et al (1999) .
Methods

Study population
The Blue Mountains Eye Study (BMES) is a populationbased cohort study of common eye diseases in residents aged 49 y or older living in a defined area, west of Sydney, Australia. This population is representative of older Australians in most respects (Mitchell et al, 1995) . Figure 1 illustrates the attrition of subjects from the study. The Blue Mountains Eye Study was approved by the Western Sydney Human Ethics Committee and written, informed consent was obtained from all participants.
Food frequency questionnaire (FFQ)
The 145-item semi-quantitative FFQ used was modified for Australian diet and vernacular from an early Willett (1988) FFQ, and included portion size estimates, as well as frequency, strength, brand and type of supplements. Participants were asked to include brand and type of certain foods which contained fortified folate, such as fruit juice, breakfast cereals and breads. Breakfast cereals were the most commonly consumed fortified item (fortified content range 167 -333 mg folate=100 g). The instrument was validated against three separate 4 day weighed food records, collected at different seasons over a year, in randomly Folate intake in an older population VM Flood et al selected subjects who agreed to participate (n ¼ 79) (Smith et al, 1998) . Dietary intakes were estimated using the Australian Tables of Food Composition (Nuttab90) database to which folate values were added from the 1995 Australian National Nutrition Survey database (DCSH, 1990; ANZFA, 1999) . Data on folate values of fortified products available in Australia in 1999 were also included. Potential fortification values for all foods permitted in accordance with standard A9 of the Food Standards Code were also used (Figure 2 ; ANZFA, 1995). The amounts described in Figure 2 refer to the total folate content of the food (ie both naturally occurring and added). Additional calculations were conducted to determine the effect of adding the folate amount described to the naturally occurring folate, so that the total exceeds the amount described, since the Food Standard A9 does not state an upper limit and some manufacturers choose to add the RDI amount to the natural folate content of the food (Abraham and Webb, 2000) .
Data modelling
Four models were constructed to estimate folate intake:
Model 4 reflects the specification outlined in the Food Standard A9 of the Australian Food Standards code A9 (1995), applied to universal fortification, as described in Figure 2 . In models 3 and 4 for foods that contained flour, the proportion of flour used in foods, eg in cakes and scones, was calculated using recipes described in the UK Composition of Foods RSC=MAFF, 1991) . These four models were applied to the food intake described by all 2895 subjects with usable FFQs.
Calculating bioavailability
Dietary folate intakes were calculated from the food tables, and expressed in micrograms, unadjusted for bioavailability. An allowance for the bioavailability of folate from supplements and fortified food products was also calculated, expressed as Dietary Folate Equivalents (DFE) in accordance with US recommendations, as follows: 1 mg DFE ¼ (mg food folate þ (1.7Â mg synthetic folic acid) (IOM, 1998) .
Statistical analyses
Differences in mean folate intake between the four models were assessed using Student's t-tests, separately for women and men. Differences between proportions consuming below and above the various cut-off points of folate intake were calculated using Z-ratios. Cut-off points used were: (1) Table 1 were all statistically significant. For example, the proportion of women consuming less than 200 mg was 9.6% in model 1 and 6.2% in model 2 (P ¼ 0.0002); the proportion of men consuming less than 320 mg in model 1 was 46.9% and in model 2 34.4% (P<0.0001). Table 2 shows the mean intake (s.d.) from diet and supplements; 10% of women and 7% of men consumed a vitamin supplement containing folate. Mean folate content of these supplements was 284 mg (female consumers) and 216 mg (male consumers), but this difference was not statistically significant, P ¼ 0.186. The overall effect of supplements on the mean intake of the group was relatively small, but statistically significant (15 -30 mg more, P<0.0001 for all models between Tables 1 and 2 ). Differences in mean folate intakes between the models were all statistically significant (P<0.0001).
The proportion of subjects consuming less than 200 and 320 mg form a similar pattern to those in Table 1 . However, a slightly higher proportion of people exceeded 1000 mg when supplement intake was included. Differences in the proportions with intakes below and above these cut-off points for the different models were significant, with a few exceptions. The differences above 1000 mg were not significantly different between models 1 and 2, and between models 2 and 3. However, a significantly higher proportion exceeded 1000 mg, using the 50% RDI model (5%) compared to the 25% RDI model (1%; P<0.0001), and taking into account an individual's supplement usage. Yet, fewer persons consumed less than 320 mg (5.8 vs 17.1% in males, P<0.0001; 6.8 vs 21.2% in females, P<0.0001). Table 3 shows the mean intake (s.d.) in terms of dietary folate equivalents (DFE), taking into account the bioavailability of folic acid from supplements and fortified foods. Fewer people consumed less than the cut-off points of 200 and 320 mg for each subsequent model. However, substantially more people would consume greater than 1000 mg DFE, particularly in model 4 (19.5% women, 24.1% men) -a much higher proportion than for model 3 (P<0.0001). This table also describes the proportion of people consuming greater than 1250 mg DFE and 1500 mg Less than five subjects in cell, difference in proportion determined using the 95% CI. Table 2 The effect of diet plus supplements: mean total folate intake from diet and supplements and the proportion of subjects estimated to consume <200, <320 and >1000 mg, by gender (1619 women, 1276 men), for the four models of fortification Less than five subjects in cell, difference in proportion determined using the 95% CI.
Folate intake in an older population VM Flood et al DFE. In the 50% model, about two-thirds fewer consume amounts greater than 1250 mg DFE (6% in women, 8.5% in men compared to 19.6% and 24.1%, respectively). For the data presented in Tables 1 -3, at the 320 mg level, no heterogeneity was found between any of the models or gender subgroups. Table 4 describes the proportion of subjects exceeding the 1000 mg tolerable upper safety limit, from synthetic folic acid sources only, ie from fortified foods and supplements. This method does not allow for the increased bioavailability of SFA. The data is presented using two assumptions of folate fortification: (1) the folate content of the fortified foods totals the amount described in Food Standard A9; (2) the folate content of the fortified foods is the amount described in the Food Standard A9 added to the amount naturally contained in the food. In assumption 1, in models 1 -3, the only subjects to exceed 1000 mg are those consuming folic acid supplements. A slightly higher proportion could exceed 1000 mg from SFA in the 50% universal model, but it remains a small proportion of the population (0.5%). In assumption 2, the 50% model has another 6 subjects who exceed 1000 mg from SFA, but in total this remains a small proportion of the population (0.7%). The proportion of subjects exceeding 1250 mg of SFA has also been described. This varies from 0.1 to 0.4%. Figure 3 shows the most important food sources of mean dietary folate intake in each model, on a per capita basis. These foods are included as individual items in the 145 item FFQ. Considerably more foods than those listed were used in the modelling. Wholemeal bread was a major contributor in each model, and in all but model 2 was the leading contributor to dietary folate intake. Other foods provided important contributions to folate intake because they were consumed frequently and=or in large amounts, although they are not high sources of folate, eg tea and potato, and beer among men (data not shown in table: 9.1 mg=day). Breakfast cereal was the leading contributor to the folate intake at current fortification levels in model 2, reflecting the comparatively high uptake of fortification in breakfast cereals.
Discussion
The current voluntary folate fortification policy has had little impact on the folate intake of this group of older Table 3 Total dietary folate equivalents and proportion of subjects estimated to consume <200, <320 and >1000 mg, by gender (from diet and supplements, allowing for bioavailability), for four models of fortification Table 4 The proportion of subjects exceeding 1000 mg of folic acid intake from synthetic sources only, ie from fortified foods and supplements (total females ¼ 1619; total males ¼ 1276)
>1000 mg synthetic folic acid, % (n) >1000 mg synthetic folic acid, % (n) Assumption 1: folate fortified foods total the amount described in the Food Standard A9 (Figure 2 ). Assumption 2: fortified folic acid is added to the natural folate content of the foods to be fortified.
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Australians, as relatively few food staples have been fortified to date. About one-third of this population consume less than the US EAR of 320 mg, but if universal folate fortification were adopted in Australia, it would substantially increase folate intakes. Folate intake from diet alone would increase by a mean of 55 and 60 mg in women and men, respectively, by adopting the 25% universal fortification model. The proportion of people falling below the US EAR of 320 mg would be greatly reduced from about onethird to about one-fifth in the 25% model; and to less than 10% in the 50% model. When folate bioavailability is taken into account, the proportion of older people in our study who fall below the 320 mg level is lower, but the number consuming greater than 1000 mg would increase substantially at the 50% universal fortification level. However, only a few subjects would be consuming greater than 1000 mg of SFA (0.5%), and most of these people exceed this level because they consume supplements.
The estimates of dietary folate intakes in this population-based study were obtained from a relatively extensive 145-item food frequency questionnaire. Folate from natural sources, particularly fruit and vegetables, may have been overestimated because of the tendency of FFQs to overestimate intakes of these foods (Howarth, 1990; Willett, 1998) . On the other hand, the food frequency method may underestimate intakes of specific nutrients if the food list does not include all the important food sources of a nutrient of interest or if serving size is not quantified. Because our FFQ is an extensive list and questions respondents about extra foods consumed and includes serving sizes, we consider it unlikely that we have missed food items that are a major contributor to total folate consumption in this population. Thus, it is more likely that our FFQ data may overestimate total folate consumption from natural sources for the individuals in our study, so that our projected number consuming >1000 mg from diet may be somewhat overestimated. For this reason, we conducted sensitivity analyses, assessing the proportion likely to consume over 1250 and 1500 mg of DFE and SFA. While the proportions decreased, there still remained about 6% of females and 8% of males consuming >1250 mg DFE. However, these sensitivity analyses are not as relevant when considering SFA only since the majority of synthetic folic acid is provided by folate supplements (not by diet) in subjects exceeding 1000 mg from SFA. Nevertheless, we conducted additional sensitivity analyses of those exceeding 1250 mg of SFA only. From the sensitivity analysis, an unbiased accurate estimate of the likely prevalence of SFA consumption over 1000 mg is likely to be somewhere between 0.1 and 0.4%. Universal folate fortification of foods at a level of 50% RDI per reference serving will increase the prevalence of unacceptably high folate consumption by only 0.2% among females and up to 0.4% among males. These estimates are low, given the derivation of the accepted upper limit of 1000 mg SFA (IOM, 1998) .
While the primary intended health benefit of folate fortification (reduction of NTDs) is regarded by policymakers as large, and the risk of one putative adverse effect (masking B 12 deficiency) is likely to be small, both are relatively rare conditions, and the prevalence of adverse outcomes is undocumented. Prior to the commencement of fortification in Australia, NTDs occurred in approximately 6 per 10 000 births and up to 12 terminations per 10 000 Figure 3 The main foods contributing to mean folate intake (mg) of various models.
Folate intake in an older population VM Flood et al births were due to neural tube defects, and about 50 -66% of these cases are thought to be preventable by fortification (Lancaster and Hurst 2000; NHMRC, 1994) . Tucker et al (1996) have estimated that, in the USA, only 0.14% of older subjects with poor serum B 12 status (<185 pmol=l) are likely to consume greater than 1000 mg of folate per day, and an even smaller proportion may have the B 12 deficiency masked. Thus, fortification is thought to prevent more cases of NTD than it may cause cases of masked B 12 deficiency among the elderly. In addition, the possible benefit of fortification in reducing CVD, by lowering homocysteine levels among the elderly could be large, estimated at 5 -10% reduction of risks for CVD (Tucker et al, 1996; Boushey et al, 1995) . There are many untested assumptions in estimating and weighing up these benefits and risks. The prevalence of vitamin B 12 deficiency among the elderly in Australia is not known. Preliminary data from our study (n ¼ 371) shows that 22% have a serum B 12 level below 185 pmol=l, suggesting possible deficiency. This rate is considerably higher than previously reported in two studies of older populations in the USA and UK (12 and 13%; Lindenbaum et al, 1994; Stott et al, 1997) . Moreover, there is no practical means at present by which to monitor or report the prevalence of masking which may occur through lack of diagnosis or inappropriate treatment, which then progresses to neurological degeneration (Abraham & Webb, 2000) . The maximum intake at which the risk of masking would be likely to occur has not been empirically established, though the IOM have recommended an upper limit of 1000 mg from synthetic folic acid (IOM, 1998) . Finally, the benefits of folate fortification and supplementation in reducing CHD by lowering homocysteine levels have yet to be confirmed in randomized controlled trials. Thus, the potential benefits of fortification can not yet be fully assessed, and the risk of adverse outcomes, while likely to be rare, should not be ignored.
One option to prevent adverse outcomes is to add vitamin B 12 to fortified foods. However, given the small increase in the proportion exceeding folate intakes of 1000 mg from synthetic folic acid from universal folate fortification, in our study, a recommendation about concurrent vitamin B 12 fortification of foods is unwarranted. However, given that most of those at risk from unacceptably high folate intake currently obtain most of their SFA from vitamin supplements, it is recommended that vitamin B 12 be included in any vitamin supplements containing folate. Although most folate supplements in Australia contain vitamin B 12 , this is at the discretion of the manufacturers and is not regulated. It is recommended that such a regulation be adopted.
Conclusion
With widespread adoption of folate fortification to universal fortification at the 25% RDI level, about 90% of older Australians are likely to consume greater than the recommended 320 mg DFE, with 0.4% consuming greater than 1000 mg SFA. With universal fortification at the 50% RDI level, over 95% are likely to consume more than 320 mg, with fewer than 0.5% consuming more than the safety level of 1000 mg SFA. As most of those who currently consume or are predicted to consume over 1000 mg SFA take supplements containing folic acid, it is highly recommended that vitamin B 12 be included in any vitamin supplements containing folate and that regulation of therapeutic goods so specify.
